Q2 2026 13F · SEC CIK 1802967
Tao Capital Management LP
Hedge fundFiled 2026-08-14 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $1.9B
- Reported positions
- 6
- Top holdings a year, 3 yrs
- +73.3%
- Average holding period
- 2 qtrs
Tao Capital Management LP is a hedge fund that reported 6 positions worth $1.9B in its Q2 2026 13F, filed 2026-08-14. Its largest holdings were Space Exploration Techn Corp (SPCX, 93.8%), Twist Bioscience Corp (TWST, 2.5%), Tesla Inc (TSLA, 1.9%). A portfolio copying its top holdings returned 73.3% a year over the last 3 years, against 20.4% for the S&P 500.
Tao Capital Management LP holdings all 6 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| SPCXSpace Exploration Techn Corp | 93.8% | — | $1.8B |
| TWSTTwist Bioscience Corp | 2.5% | -42.2% | $49.3M |
| TSLATesla Inc | 1.9% | +0.0% | $36.3M |
| HHyatt Hotels Corp | 0.7% | +0.0% | $13.6M |
| MDGLMadrigal Pharmaceuticals Inc | 0.6% | +0.0% | $11.3M |
| TXG10x Genomics Inc | 0.6% | +34.4% | $10.9M |
What Tao Capital Management LP bought and sold in Q2 2026, against Q1 2026.
New positions
- SPCX Space Exploration Techn Corp93.8% of 13F
Added to
- TXG 10x Genomics Inc+34.4% shares
Reduced
- TWST Twist Bioscience Corp-42.2% shares
Sold out
- OUST Ouster Incwas 13.1%
- MASS 908 Devices Incwas 2.9%
- WRBY Warby Parker Incwas 2.4%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- +132.9% /yr
- S&P 500 +20.1%
- 3 years
- +73.3% /yr
- S&P 500 +20.4%
- 5 years
- +17.8% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $1.9B | 6 |
| Q1 2026 | $118.8M | 8 |
| Q4 2025 | $116.2M | 8 |
| Q3 2025 | $132.2M | 10 |
| Q2 2025 | $136.4M | 9 |
| Q1 2025 | $116.1M | 9 |
| Q4 2024 | $143.3M | 10 |
| Q3 2024 | $110.4M | 10 |
| Q2 2024 | $122.0M | 10 |
| Q1 2024 | $105.5M | 10 |
| Q4 2023 | $109.3M | 12 |
| Q3 2023 | $129.1M | 11 |
Questions about Tao Capital Management LP's portfolio
What stocks does Tao Capital Management LP own?
Tao Capital Management LP's latest 13F, for Q2 2026 and filed Aug 14, 2026, lists 6 positions worth $1.9B. The largest are Space Exploration Techn Corp (SPCX) at 93.8%, Twist Bioscience Corp (TWST) at 2.5%, Tesla Inc (TSLA) at 1.9%, Hyatt Hotels Corp (H) at 0.7% and Madrigal Pharmaceuticals Inc (MDGL) at 0.6%.
What did Tao Capital Management LP buy last quarter?
In Q2 2026, Tao Capital Management LP added a new position in Space Exploration Techn Corp (SPCX) and 10x Genomics Inc (TXG) (+34.4% shares), compared with its Q1 2026 filing.
What did Tao Capital Management LP sell last quarter?
In Q2 2026, Tao Capital Management LP sold all of Ouster Inc (OUST), sold all of 908 Devices Inc (MASS), sold all of Warby Parker Inc (WRBY) and Twist Bioscience Corp (TWST) (-42.2% shares), compared with its Q1 2026 filing.
How has Tao Capital Management LP's portfolio performed?
A portfolio copying Tao Capital Management LP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +73.3% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +132.9% against +20.1%. Over 5 years: +17.8% a year against +11.6%.
When is Tao Capital Management LP's next 13F filing due?
13F filings are due 45 days after each quarter ends. Tao Capital Management LP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.